decemb
seri
acut
respiratori
ill
report
wuhan
hubei
provinc
china
novel
coronaviru
initi
name
sever
acut
respiratori
syndrom
coronaviru
identifi
caus
diseas
chines
center
diseas
control
prevent
cdc
diseas
design
coronaviru
diseas
rapidli
spread
citi
china
becom
public
health
emerg
intern
concern
pheic
follow
global
spread
clinic
manifest
fever
cough
muscl
pain
fatigu
diarrhea
pneumonia
caus
death
sever
case
februari
china
report
case
confirm
fatal
sinc
effect
immun
respons
viral
infect
depend
activ
cytotox
cell
clear
infect
kill
virusinfect
cell
boost
number
function
cell
patient
critic
success
recoveri
recent
studi
report
case
display
low
circul
lymphocyt
count
howev
factor
might
caus
reduct
count
activ
statu
cell
patient
remain
uninvestig
retrospect
analyz
clinic
data
case
admit
gener
hospit
central
theatr
command
hanyang
hospit
wuhan
decemb
januari
also
compar
express
exhaust
marker
surfac
cell
healthi
control
result
thu
provid
preliminari
demonstr
cell
exhaust
infect
suggest
aggress
earli
intervent
may
requir
patient
low
lymphocyt
count
patient
medic
record
patient
age
day
year
confirm
admit
gener
hospit
central
theatr
command
hanyang
hospit
wuhan
decemb
januari
healthi
peopl
age
year
came
hospit
routin
physic
examin
collect
retrospect
analyz
diagnosi
base
new
coronaviru
pneumonia
prevent
control
program
edit
publish
nation
health
commiss
china
patient
laboratoryconfirm
posit
use
quantit
within
cohort
analyz
admit
intens
care
unit
icu
requir
highflow
nasal
cannula
higherlevel
oxygen
support
measur
correct
hypoxaemia
hypoxaemia
defin
arteri
oxygen
tension
inspiratori
oxygen
fraction
less
mm
hg
arteri
oxygen
satur
lower
accord
stage
infecti
diseas
prodrom
period
phase
host
begin
experi
gener
sign
symptom
ill
period
overtli
symptomat
period
phase
sign
symptom
diseas
obviou
sever
posit
laboratori
find
chest
imag
icu
patient
icu
period
phase
symptom
obviou
sever
declin
period
phase
clinic
symptom
begin
declin
laboratori
find
chest
imag
improv
arteri
oxygen
satur
return
normal
review
clinic
record
nurs
record
laboratori
find
chest
xray
ct
scan
patient
physic
examin
record
healthi
peopl
inform
obtain
curat
customis
data
collect
form
three
investig
c
wang
z
fen
chen
independ
review
data
collect
form
verifi
data
accuraci
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
biolegend
biolegend
antibodi
stain
cell
measur
flow
cytometri
lsr
fortessa
cell
analyz
bd
bioscienc
data
analyz
use
folwjo
softwar
treestar
experiment
procedur
complet
biosafeti
level
ii
plu
condit
statist
analysi
statist
analys
perform
use
graphpad
prism
version
graphpad
softwar
inc
san
diego
ca
usa
continu
variabl
directli
express
rang
categor
variabl
express
numbersnumb
p
valu
nonpair
test
pair
test
role
fund
sourc
fund
agenc
particip
studi
design
data
collect
data
analysi
manuscript
write
correspond
author
respons
aspect
studi
ensur
issu
relat
accuraci
integr
part
work
properli
investig
resolv
final
version
approv
author
retrospect
analysi
patient
case
lymphocyt
count
record
patient
remark
low
total
cell
count
cell
count
respect
among
milder
patient
nonicu
group
median
valu
total
cell
cell
count
respect
median
valu
decreas
respect
icu
group
figur
count
total
cell
cell
significantli
lower
icu
patient
nonicu
case
figur
patient
categor
three
group
base
age
year
old
year
year
agedepend
reduct
cell
number
observ
patient
lowest
cell
number
found
patient
year
old
figur
suggest
potenti
caus
increas
suscept
elderli
patient
next
retrospect
review
cell
number
case
nonicu
patient
within
one
center
gener
hospit
central
theatr
command
nonicu
patient
divid
four
group
base
clinic
outcom
among
patient
case
mildmoder
case
sever
case
critic
condit
perish
occur
statist
analysi
show
cell
number
includ
total
cell
cell
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
sever
critic
perish
group
significantli
lower
mildmoder
group
importantli
number
total
cell
cell
cell
sever
perish
group
lower
respect
figur
result
suggest
aggress
intervent
may
requir
nonicu
patient
even
absenc
sever
symptom
cell
count
fall
critic
threshold
express
angiotensin
convert
enzym
predict
receptor
virus
absent
cell
suggest
depress
count
patient
mention
figur
like
caus
direct
infect
cell
therefor
examin
concentr
serum
cytokin
includ
patient
explor
influenc
cytokin
signal
found
level
significantli
increas
infect
patient
statist
analysi
illustr
level
icu
patient
significantli
higher
nonicu
patient
figur
next
investig
relationship
cell
count
within
nonicu
patient
interestingli
concentr
three
cytokin
neg
correl
total
cell
count
count
count
respect
figur
subsequ
summar
follow
data
cytokin
concentr
cell
number
ten
patient
follow
cours
inpati
care
interestingli
serum
level
significantli
decreas
patient
declin
period
compar
ill
period
count
total
cell
cell
subset
recov
declin
period
figur
phenomena
suggest
decreas
cell
seen
patient
like
result
high
serum
concentr
neg
regul
cell
surviv
prolifer
beyond
chang
number
cours
infect
cell
may
display
limit
function
prolong
infect
result
exhaust
associ
express
immuneinhibitori
factor
includ
cell
surfac
therefor
examin
whether
cell
patient
exhaust
phenotyp
fac
analysi
illustr
cell
patient
markedli
higher
level
compar
healthi
control
figur
furthermor
statist
analysi
show
percentag
cell
icu
patient
significantli
higher
nonicu
case
healthi
control
figur
indic
virus
induc
cell
exhaust
patient
particularli
requir
icu
care
three
patient
followup
inpati
care
express
exhaust
marker
includ
surfac
cell
diseas
progress
detect
fac
show
patient
low
level
cell
prodrom
stage
howev
level
cell
increas
overtli
symptomat
stage
highest
level
seen
icu
period
figur
similarli
higher
level
observ
cell
patient
icu
stage
although
enhanc
express
cell
obvious
diseas
progress
figur
result
secret
array
molecul
perforin
granzym
erad
virus
host
time
helper
cell
th
assist
cytotox
cell
b
cell
enhanc
abil
clear
pathogen
howev
persist
stimul
viru
may
induc
cell
exhaust
lead
loss
cytokin
product
capabl
reduc
function
earlier
studi
unclear
regard
number
function
cell
patient
albeit
suggest
depress
lymphocyt
count
report
retrospect
review
number
total
cell
cell
subset
total
patient
nonicu
patient
found
case
underw
decreas
total
cell
cell
cell
howev
icu
group
total
patient
show
decreas
total
cell
cell
importantli
patient
display
decreas
cell
also
analyz
nonicu
patient
greater
detail
found
aggress
intervent
may
necessari
preempt
develop
sever
symptom
patient
low
cell
count
cytokin
storm
phenomenon
excess
inflammatori
reaction
cytokin
rapidli
produc
larg
amount
respons
microbi
infect
phenomenon
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
consid
import
contributor
acut
respiratori
distress
syndrom
ard
multipl
organ
dysfunct
syndrom
mod
also
implic
set
respiratori
viral
infect
sar
avian
influenza
viru
infect
infect
show
level
gcsf
significantli
higher
patient
consist
report
also
found
secret
cytokin
includ
increas
patient
interestingli
number
total
cell
cell
neg
correl
level
respect
figur
suggest
cytokin
promot
cell
decreas
patient
proinflammatori
cytokin
promot
cell
apoptosi
via
interact
receptor
express
increas
age
cell
current
analysi
demonstr
patient
year
old
lower
cell
number
indic
might
directli
involv
induc
cell
loss
patient
promptli
transient
produc
respons
infect
tissu
injuri
contribut
host
defens
stimul
acut
phase
respons
immun
reaction
dysregul
continu
synthesi
shown
play
patholog
role
chronic
inflamm
infect
tocilizumab
human
receptor
antibodi
develop
approv
treatment
rheumatoid
arthriti
ra
juvenil
idiopath
arthriti
moreov
tocilizumab
shown
effect
cytokin
releas
syndrom
result
cart
cell
infus
b
cell
acut
lymphoblast
leukemia
whether
tocilizumab
restor
cell
count
patient
suppress
signal
remain
uninvestig
one
interest
question
sourc
cytokin
infect
previou
studi
valid
secret
cytokin
includ
mainli
cell
macrophag
monocyt
etc
base
result
suggest
secret
cytokin
origin
cell
howev
cytokin
storm
turn
may
promot
apoptosi
necrosi
cell
consequ
lead
reduct
previou
work
demonstr
monocyt
macrophag
produc
proinflammatori
cytokin
murin
hepat
viru
infect
whether
also
trigger
cytokin
releas
monocyt
macrophag
patient
need
investig
work
progress
hospit
cell
exhaust
state
cell
dysfunct
aris
mani
chronic
infect
cancer
defin
poor
effector
function
sustain
express
inhibitori
receptor
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
transcript
state
distinct
function
effector
memori
cell
fac
analysi
found
cell
cell
higher
level
viru
infect
patient
particularli
deriv
icu
patient
sinc
chang
could
also
observ
longitudin
followup
sever
patient
prodrom
icu
care
figur
inhibitori
cytokin
prevent
cell
prolifer
also
induc
cell
exhaust
import
block
function
shown
success
prevent
cell
exhaust
anim
model
chronic
infect
demonstr
patient
high
level
serum
follow
infect
also
display
high
level
exhaust
marker
cell
suggest
might
mechanist
respons
applic
potent
antivir
treatment
prevent
progress
cell
exhaust
suscept
patient
may
thu
critic
recoveri
read
great
interest
success
applic
remdesivir
cure
patient
us
clinic
trial
indic
may
signific
potenti
antivir
taken
togeth
conclud
cell
decreas
exhaust
patient
cytokin
might
directli
mediat
cell
reduct
thu
new
therapeut
measur
need
treatment
icu
patient
may
even
necessari
earli
preempt
diseas
progress
higherrisk
patient
low
cell
count
author
declar
financi
commerci
conflict
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
